Results 181 to 190 of about 866,426 (291)

Harnessing organoid technology in urological cancer: advances and applications in urinary system tumors. [PDF]

World J Surg Oncol
Wang X, Lin D, Feng N.
europepmc   +1 more source

Lower urinary system symptoms and affecting factors in female students staying in a dormitory. [PDF]

Rev Assoc Med Bras (1992), 2022
Özcan H, Beji NK.
europepmc   +1 more source

Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next‐Generation Approaches

Advanced Science, EarlyView.
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey, Sudhir Kumar Rai, Li Ma, Lauren Higa, Vedbar Khadka, Hua Yang, Youping Deng   +6 more
wiley   +1 more source

Causal relationships between immune cells and common urinary system tumors: A bidirectional analysis of Mendelian randomization. [PDF]

Medicine (Baltimore)
Liu Z, Tu J, Long J, Guo L.
europepmc   +1 more source

Variants in genes related to development of the urinary system are associated with Mayer-Rokitansky-Küster-Hauser syndrome. [PDF]

Hum Genomics, 2022
Chu C, Li L, Li S, Zhou Q, Zheng P, Zhang YD, Duan AH, Lu D, Wu YM.   +8 more
europepmc   +1 more source

Combating VEGFA‐siRNA‐Induced Metabolic Reprogramming via Glucose Utilization Deprivation

Advanced Science, EarlyView.
An ionizable lipid nanoparticle co‐delivers VEGFA siRNA and glucose oxidase to tumors to counteract VEGFA knockdown‐induced, glutamine‐driven metabolic compensation. Enzymatic glucose consumption reverses the adaptive pathways and restores metabolism toward baseline, thereby sensitizing tumors to therapy.
Lulu Zheng, Shuai Guo, Yingjixing Luo, Pengfei Wu, Haiyin Yang, Yingqiu Xie, Yuchuan Fan, Qing Liu, Bo Hu, Jia Huang, Yuanyu Huang   +10 more
wiley   +1 more source

Evaluation of the Risk of Urinary System Stone Recurrence Using Anthropometric Measurements and Lifestyle Behaviors in a Developed Artificial Intelligence Model. [PDF]

Diagnostics (Basel)
Yasar H, Yildirim K, Karaduman M, Kolcu B, Ezer M, Suceken FY, Bicaklioğlu F, Aydin ME, Kaya C, Yildirim M, Sarica K.   +10 more
europepmc   +1 more source

Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia [PDF]

, 1981
Jüngst, Dieter, Karl, Hans Josef, Lazik, E., Tauber, R.   +3 more
core   +1 more source

O‐GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer

Advanced Science, EarlyView.
This article unveils a critical mechanism of immune evasion in bladder cancer, which the O‐GlcNAc modification of TAP1 disrupts antigen presentation. This modification triggers HLA‐A degradation, shielding tumor cells from CD8+ T cell attack. The findings highlight targeting this pathway as a promising therapeutic avenue to sensitize tumors to ...
Jinpeng Wu, Xueting Ren, Zhen Zhai, Lu Wang, Liang Liang, Zengqi Tan, Jiazhen Zhao, Yuxuan Han, Yuhan Li, Feng Guan, Xiang Li   +10 more
wiley   +1 more source

Comparative evaluation of large language models performance in medical education using urinary system histology assessment. [PDF]

Sci Rep
Szabó A, Laein GD.
europepmc   +1 more source